Daniel Ackerman, PhD

My recent work in the PIGI lab has focused on overcoming difficulties surrounding the generation of patient-derived models of primary liver cancer. This emphasis on improving cancer models stems from my conviction that therapeutic translation in cancer research could be greatly accelerated by increasing the availability of models that represent the diversity and complexity of human disease.